Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Table Index

View All
Pharmacological treatments of mania in children and adolescents
Physiological risk factors for QTc prolongation and arrhythmia
Possible causes of psychiatric symptoms in people with epilepsy (PWE) and their management
Potential pharmacodynamic interactions with antiretrovirals
Prescribing in attention deficit hyperactivity disorder (ADHD)
Psychosocial and pharmacological interventions in benzodiazepine withdrawal
Psychotropic drug groups in hepatic impairment
Psychotropic drugs: choice in patients who continue to drink
Psychotropic drugs in overdose
Psychotropic medications approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), European Medicines Agency and the US Food and Drug Administration for children and adolescents (January 2024)
Psychotropics and driving
Psychotropics in epilepsy
Randomised controlled trials (RCTs) of the use of long-acting injections (LAIs) in bipolar affective disorder
Recommendations for delayed maintenance dose of Ari 2MRTU
Recommendations for treatment for depression in multiple sclerosis (MS)
Recommendations for treatment of depression in Parkinson's disease (PD)
Recommendations for treatment of psychosis in Parkinson's disease (PD)
Recommendations for using psychotropics in atrial fibrillation (AF)
Recommended actions in response to clozapine concentrations
Recommended drugs and drugs to avoid in dementia
Recommended drugs for rapid tranquillisation if the oral route is refused or has proven ineffective
Recommended ECG monitoring for people taking methadone
Recommended first-line treatments for acute mania
Recommended first-line treatments for bipolar depression
Recommended minimum effective doses of antidepressants
Recommended monitoring for diabetes in patients receiving antipsychotic drugs
Recommended psychotropics in renal impairment
Recommended treatment strategy fo rapid-cycling bipolar disorder
Reduction or discontinuation regimen for antipsychotic drugs in BPSD - a guide57,58
Reductions of olanzapine dose by up to 5 percentage points of D2 occupancy at each step, adjusted to allow use of quarter tablets